Abstract
Introduction
An integrated PET/MRI scanner has been used in selected cases of pediatric brain tumor patients to obtain additional metabolic information about lesions for preoperative biopsy planning and navigation.
Patients and methods
Four patients, age 9–16 years, received PET/MRI scans employing [11C]methionine positron emission tomography (PET) and contrast-enhanced 3D-MR sequences for neuronavigation. PET and MR sequences have been matched for neurosurgical guidance. An infrared camera-based neuronavigation system was employed with co-registered MR and PET images fused to hybrid images for preoperative planning, stereotactic biopsy planning, and/or intraoperative guidance.
Results
All patients showed hot spots of increased amino acid transport in PET and contrast-enhancing lesions in MRI. In three of the four patients, PET hot spots were congruent with contrast-enhancing areas in MRI. In two patients, frame-based stereotactic biopsies were taken from thalamo-mesencephalic lesions. One patient underwent second-look surgery for the suspicion of recurrent malignant glioma of the posterior fossa. One incidental frontal mass lesion was subtotally resected. No complications occurred. Hybrid imaging was helpful during the procedures to obtain representative histopathologic specimens and for surgical guidance during resection. Co-registered images did match with intraoperative landmarks, tumor borders, and histopathologic specimens.
Conclusion
The integrated PET/MRI scanner offers co-registered multimodal, high-resolution data for neuronavigation with reduced radiation exposure compared to PET/CT scans. One examination session provides all necessary data for neuronavigation and preoperative planning, avoiding additional anesthesia in the small patients. Hybrid multimodality imaging may improve safety and yield additional information when obtaining representative histopathologic specimens of brain tumors.
Similar content being viewed by others
References
Bailey DL, Barthel H, Beyer T, Boellaard R, Gückel B, Hellwig D, Herzog H, Pichler BJ, Quick HH, Sabri O, Scheffler K, Schlemmer HP, Schwenzer NF, Wehrl HF (2012) Summary report of the first international workshop on PET/MR imaging, March 19-23, 2012, Tübingen, Germany. Mol Imaging Biol 15(4):361–371
Biermann M, Schwarzlmüller T, Fasmer KE, Reitan BC, Johnsen B, Rosendahl K (2013) Is there a role for PET-CT and SPECT-CT in pediatric oncology? Acta Radiol 54(9):1037–1045. doi:10.1258/ar.2012.120616, Epub 2013 Apr 30. Review
Hirsch FW, Sattler B, Sorge I, Kurch L, Viehweger A, Ritter L, Werner P, Jochimsen T, Barthel H, Bierbach U, Till H, Sabri O, Kluge R (2013) PET/MR in children. Initial clinical experience in paediatric oncology using an integrated PET/MR scanner. Pediatr Radiol 43(7):860–875. doi:10.1007/s00247-012-2570-4, Epub 2013 Jan 11
Imani F, Boada FE, Lieberman FS, Davis DK, Deeb EL, Mountz JM (2012) Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro deoxyglucose positron emission tomography for assessment of brain tumor progression. J Neuroimaging 22(2):184–190
Jadvar H, Colletti PM (2014) Competitive advantage of PET/MRI. Eur J Radiol 83(1):84–94
Mertens K, Acou M, Van Hauwe J, De Ruyck I, Van den Broecke C, Kalala JP, D’Asseler Y, Goethals I (2013) Validation of 18F-FDG PET at conventional and delayed intervals for the discrimination of high-grade from low-grade gliomas: a stereotactic PET and MRI study. Clin Nucl Med 38(7):495–500. doi:10.1097/RLU.0b013e318292a753
Pichler BJ, Kolb A, Nägele T, Schlemmer HP (2010) PET/MRI: paving the way for next generation of clinical multimodality imaging applications. J Nucl Med 51:333–336
Pirotte BJ, Lubansu A, Massager N, Wikler D, Van Bogaert P, Levivier M, Brotchi J, Goldman S (2010) Clinical interest of integrating positron emission tomography imaging in the workup of 55 children with incidentally diagnosed brain lesions. J Neurosurg Pediatr 5(5):479–485
Pirotte BJ, Lubansu A, Massager N, Wikler D, Van Bogaert P, Levivier M, Brotchi J, Goldman S (2010) Clinical impact of integrating positron emission tomography during surgery in 85 children with brain tumor. J Neurosurg Pediatr 5(5):486–499
Sattler B, Jochimsen T, Barthel H, Sommerfeld K, Stumpp P, Hoffmann KT, Gutberlet M, Villringer A, Kahn T, Sabri O (2013) Physical and organizational provision for installation, regulatory requirements and implementation of a simultaneous hybrid PET/MR-imaging system in an integrated research and clinical setting. MAGMA 26(1):159–171
Sauter AW, Wehrl HF, Kolb A, Judenhofer MS, Pichler BJ (2010) Combined PET/MR: one step further in multimodality imaging. Trends Mol Med 16:508–515
Thorsen F, Fite B, Mahakian LM, Seo JW, Qin S, Harrison V, Johnson S, Ingham E, Caskey C, Sundstrøm T, Meade TJ, Harter PN, Skaftnesmo KO, Ferrara KW (2013) Multimodal imaging enables early detection and characterization of changes in tumor permeability of brain metastases. J Control Release 172(3):812–822. doi:10.1016/j.jconrel.2013.10.019, Epub 2013 Oct 29
Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ (2009) Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 36(Suppl 1):56–68
Wehrl HF, Schwab J, Hasenbach K, Reischl G, Tabatabai G, Quintanilla-Martinez L, Jiru F, Chughtai K, Kiss A, Cay F, Bukala D, Heeren RM, Pichler BJ, Sauter AW (2013) Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography. Cancer Res 73(5):1470–1480. doi:10.1158/0008-5472.CAN-12-2532, Epub 2013 Jan 23
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Preuss, M., Werner, P., Barthel, H. et al. Integrated PET/MRI for planning navigated biopsies in pediatric brain tumors. Childs Nerv Syst 30, 1399–1403 (2014). https://doi.org/10.1007/s00381-014-2412-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-014-2412-9